Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics in the related topics section; no changes to study details or outcomes.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded a PubMed auto-fill note and updated the page revision to v3.3.2; the previous PubMed note and revision v3.2.0 were removed.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page removed a government funding status notice and related topic links for 'Multiple myeloma' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check23 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page context. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange Detected- Added related topic links for Multiple Myeloma and MedlinePlus Genetics to the Study Details page.SummaryDifference0.4%

- Check45 days agoChange DetectedAdded MedlinePlus Genetics topic on multiple myeloma to expand core content.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.